Tests a virtual reality app with remote therapy for memory and thinking problems
Tests a home virtual reality app for thinking problems in adults with mild memory decline.
Plain-language title generated from the registry record
Registry title: Effectiveness of TeleVR App in Cognitive Decline and MCI Patients
Key facts
- Where
- Messina, ItalySee the site
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults aged 40 to 80 with subjective cognitive decline or mild cognitive impairment (linked to Alzheimer's or Parkinson's disease). It tests a home VR program against paper-based exercises.
- Age
- 40 to 80 years
- Sex
- All sexes can join.
- Disease stage
- Subjective cognitive decline, or mild cognitive impairment due to Alzheimer's disease or Parkinson's disease, diagnosed by the criteria named in the record.
Main reasons for not taking part
- Psychiatric disorders such as major depression, psychosis or anxiety disorders
- Severe dementia
- History of cerebral ischemia
- Reasons that make a brain MRI unsafe, such as pregnancy, pacemakers or some metal implants, unless a specialist gives a written statement
- Fewer than 5 years of education
Read by machine on 12 November 2026.
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 40 and 80 years old?
Source: NCT06793735, who can take part
Where in Italy
- IRCCS Centro Neurolesi Bonino PulejoMessina, ItalyContact: Maria Grazia Maggio, PhD, PsyDTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- IRCCS Centro Neurolesi Bonino Pulejo
- Trial code
- NCT06793735
- Record updated
- 3 April 2026
- Original description
The goal of this clinical trial is to evaluate the effectiveness of a telerehabilitation program combined with a virtual reality (VR) app in improving cognitive performance and social skills in patients with Subjective Cognitive Decline (SCD) and Mild Cognitive Impairment (MCI).Read full original descriptionShow less
Effectiveness of Telerehabilitation Plus Virtual Reality App in Patients With Subjective Cognitive Decline, and Mild Cognitive Impairment
The goal of this clinical trial is to evaluate the effectiveness of a telerehabilitation program combined with a virtual reality (VR) app in improving cognitive performance and social skills in patients with Subjective Cognitive Decline (SCD) and Mild Cognitive Impairment (MCI).
The main questions it aims to answer are:
Can a VR telerehabilitation program improve cognitive functions and social skills in patients with SCD and MCI? Are there measurable changes in brain activity, eye movements, and gait patterns after the intervention? Researchers will compare telerehabilitation with a VR group (Experimental Group - EG) to a traditional paper-based cognitive rehabilitation group (Active Control Group - aCG) to determine which approach is more effective.
Participants will:
Undergo an initial assessment, including neurological exams, neuropsychological tests, brain MRI, EEG, eye movement analysis, and gait evaluation.
Participate in a 6-week intervention program:
EG: Use VR apps on smartphones/tablets at home, guided remotely by a therapist. aCG: Perform traditional cognitive exercises using paper-based tasks. Complete follow-up assessments immediately after the intervention and again after three months.
This study will help determine whether telerehabilitation with VR can provide measurable cognitive and social benefits, contributing to improved care strategies for individuals at risk of dementia.
Inclusion: Subjects diagnosed with MCI (AD and PD) according to the criteria of the National Institute on Aging-Alzheimer's Association (NIA-AA, Albert et al., 2011); Subjects diagnosed with SCD according to diagnostic criteria proposed in research settings (Molinuevo et al., 2017); All enrolled subjects must be aged between 40 and 80 years and have at least 5 years of education.
Exclusion: Presence of psychiatric disorders (major depression, psychosis, anxiety disorders); Presence of severe dementia; History of cerebral ischemia; Contraindications to brain MRI: pregnant women, pacemakers, non-latest-generation metal joint prostheses, electrodes, neurostimulators, or prostheses that may interfere with magnetic fields, unless there is a written statement of suitability from the specialist who performed the intervention.